Clinical Trial Update: Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H [NA]

View source ↗

Summary

A completed clinical trial comparing BPA leaching from two dialyzer models (Fresenius Optiflux 160NR vs Nipro ELISIO-15H) in patients with end-stage renal disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Fresenius Optiflux 160NR dialyzer (dialyzer)
• Nipro ELISIO-15H dialyzer (dialyzer)

Snippet

Sponsor: UConn Health | Conditions: End Stage Renal Disease | NA | Status: COMPLETED | Results posted: 2018-06-11